Cover Image
市场调查报告书

胞外体诊断、治疗:全球市场

Exosome Diagnostics and Therapeutics: Global Markets

出版商 BCC Research 商品编码 354591
出版日期 内容信息 英文 195 Pages
订单完成后即时交付
价格
Back to Top
胞外体诊断、治疗:全球市场 Exosome Diagnostics and Therapeutics: Global Markets
出版日期: 2018年05月16日 内容信息: 英文 195 Pages
简介

全球胞外体产业,预计2018年达2500万美金,此后以48.4%的年复合成长率成长,2023年达到1亿8,000万美元。

本报告提供全球胞外体诊断、治疗市场相关调查,全球市场及相关技术概要,世界市场趋势分析,新、传统的诊断方法分析,目前治疗、预测不久将来实现的治疗分析,市场动态分析,及主要企业简介等汇整。

第1章 简介

第2章 摘要、亮点

第3章 市场、技术背景

  • 胞外体定义、用语体系
  • 胞外体的发现
  • 胞外体的生体合成、处理
  • 胞外体的零组件
  • 胞外体的分离与检测
  • 胞外体研究、产品开发的生物信息学数据库
  • 胞外体的功能、生理功能

第4章 胞外体诊断市场

  • 诊断生物标记的胞外体蛋白质
  • 诊断生物标记的胞外体核酸
  • 对胞外体诊断产品开发来说有市场可能性的癌症诊断
  • 胞外体部门有诊断可能性的液态切片
  • 化验开发的癌症生物标记的胞外体蛋白质、核酸
  • 对胞外体诊断产品开发来说有市场可能性的CNS疾病、神经退化性疾病
  • 对胞外体诊断产品开发来说有市场可能性的感染疾病
  • 对胞外体诊断产品开发来说有市场可能性的心血管疾病
  • 对胞外体诊断产品开发来说有市场可能性的产前检查
  • 对胞外体诊断产品开发来说有市场可能性的器官移植
  • 胞外体型诊断部门的市场参与企业
    • Amarantus BioScience
    • Caris Life Sciences
    • Exosome Diagnostics
    • Exosome Sciences/Aethlon Medical
    • Exosomics Siena SPA
    • Nanosomix
    • NX Pharmagen
    • NX Prenatal
    • Orion Pharma
    • Sistemic
    • Ymir Genomics
  • 胞外体市场上目前诊断部门的评估

第5章 胞外体治疗市场

  • 内因性治疗活性
  • 免疫学的适合性
  • 货物功能
  • 胞外体中介治疗的生成
  • 胞外体治疗的市场潜在性
  • 胞外体型治疗部门的市场参与企业
    • Aegle Therapeutics
    • Aethlon Medical
    • Anjarium Biosciences
    • BioRegenerative Sciences
    • Capricor Therapeutics
    • Cell Factory
    • Codiak BioSciences
    • Creative Medical Technology Holdings (CMTH)
    • DreiRosen Pharma
    • Evox Therapeutics
    • ExoCoBio
    • ExoCyte Therapeutics
    • Exogenus Therapeutics
    • Exopharm
    • Exotech Bio
    • Exovita Biosciences
    • Intrexon Corp.
    • Kimera Labs
    • MDimune
    • MolecuVax
    • Panacea Pharmaceuticals, Inc.
    • Paradigm Pharmaceuticals
    • ReCyte
    • Regeneus
    • ReNeuron
    • Therapeutics Solutions International
    • Unicyte AG
  • 胞外体市场开发指标的临床实验
  • 胞外体市场上目前诊断部门的评估

第6章 胞外体试剂、研究工具市场

  • 概要
    • 分离方法、试剂
    • 检测方法、试剂
    • 特徵化方法、试剂
    • 工程方法、试剂
    • 其他的产品、试剂
  • 市场参与企业
    • 101Bio
    • AMSBIO
    • Cell Guidance Systems
    • Ciloa
    • Evomic Science
    • Excytex
    • ExoCan
    • HansaBiomed (Lonza)
    • IZON Science
    • NanoSight (Malvern Instruments)
    • Nanoview Biosciences
    • System Biosciences (SBI)
  • 胞外体市场上目前工具、试剂的评估

第7章 特定的生物医药品市场相关胞外体研究的影响

  • 胞外体研究带给生物标记、诊断产业的影响
  • 胞外体研究带给微型核糖核酸市场的影响
  • 胞外体研究带给液态切片市场的影响
  • 胞外体研究带给干细胞技术市场的影响
  • 胞外体研究带给产前诊断市场的影响

第8章 专利检讨/新开发

第9章 市场摘要

第10章 企业简介

BCC Research

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: BIO149B

The global market for exosome industry should reach $180.0 million by 2023 from $25 million in 2018 at a compound annual growth rate (CAGR) of 48.4% for the period 2018-2023.

Report Includes

  • 35 data tables and 35 additional tables
  • An overview of the global markets and related technologies for exosome diagnostics and therapeutics
  • Analyses of global market trends, with data from 2016 to 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Breakdowns of new and existing diagnostic methods
  • Evaluations of current therapeutics and those likely to be utilized in the near future
  • Analyses of the market's dynamics, specifically growth drivers, restraints, and opportunities
  • Company profiles of major players in the market, including Codiak BioSciences, Evox Therapeutics, Exosome Diagnostics, Inc., HansaBioMed, NonosomiX, Inc. and System Biosciences (SBI)

Report Scope

This report represents a current and important business tool to evaluate new commercial opportunities in the exosome diagnostic, therapeutic and research tools markets. The geographic scope of this study covers the U.S. and companies worldwide. This market is complex and consists of a number of different sectors, each affected differently by scientific and technological development. The report identifies the main positive and negative factors in each sector and forecasts further trends and product and assay development in every category of this industry.

Analyst Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology and industrial assay development and drug manufacturing. She has contributed to a number of scientific publications and holds several patents. She has expertise as an assay development scientist and is familiar with different research field trends and likely future developments.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources and Methodology
  • Intended Audience
  • Analyst's Credentials
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

  • Exosome Definition and Nomenclature
  • Discovery of Exosomes
  • Exosomes Biogenesis and Processing
  • Exosome Components
    • DNA in Exosomes
    • Proteins in Exosomes
    • RNA in Exosomes
  • Isolation and Detection of Exosomes
    • Isolation Techniques
    • Exosome Detection
  • Bioinformatics Databases for Exosome Research and Product Development
    • ExoCarta
    • Vesiclopedia
    • EVpedia
  • Exosome Function and Physiology

Chapter 4: Exosome Diagnostics Market

  • Exosomal Proteins as Diagnostic Biomarkers
  • Exosomal Nucleic Acids as Diagnostic Biomarkers
  • Cancer Diagnostics as Market Potential for Exosome-based Diagnostics Product Development..
    • Prostate Cancer as Potential for Diagnostics Development in Exosomes Sector
    • Breast Cancer as Potential for Diagnostics Development in Exosome Sector
    • Bladder Cancer as Potential for Diagnostics Development in Exosome Sector
    • Ovarian Cancer as Potential for Diagnostics Development in Exosome Sector
    • Lung Cancer as Potential for Diagnostics Development in the Exosome Sector
  • Liquid Biopsy as Potential for Diagnostics in Exosome Sector
  • Exosomal Proteins and Nucleic Acids as Cancer Biomarkers in Assay Development
  • CNS Disorders and Neurodegeneration Diseases as Market Potential for Exosome Diagnostics Product Development
  • Infectious Diseases as Market Potential for Exosome Diagnostics Product Development
  • Cardiovascular Diseases as Market Potential for Exosome Diagnostics Product Development .
  • Prenatal Testing as Market Potential for Exosome Diagnostics Product Development
  • Organ Transplantation as Market Potential for Exosome Diagnostics Product Development
  • Market Participants in Exosome-based Diagnostics Sector
    • Amarantus BioScience
    • Caris Life Sciences
    • Exosome Diagnostics
    • Exosome Sciences/Aethlon Medical
    • Exosomics Siena SPA
    • Nanosomix
    • NX Pharmagen
    • NX Prenatal
    • Orion Pharma
    • Sistemic
    • Ymir Genomics
    • Additional Exosome-based Diagnostics Market Participants
  • Evaluation of Current Diagnostics Sector in Exosome Market

Chapter 5: Exosome Therapeutic Market

  • Intrinsic Therapeutic Activity of Exosomes
  • Immunological Compatibility
  • Cargo Capabilities
  • Generation of Exosome-mediated Therapeutics
    • Exosome Isolation and Purification from Biofluids or Cell Culture
    • Engineering Exosomes as Therapeutic Delivery Vehicles
    • Targeting Exosomes to Specific Recipient Cells
    • Designing Exosomes as a Synthetic Vector
  • Market Potential for Exosome Therapeutics
  • Market Participants in Exosome-based Therapeutics Sector
    • Aegle Therapeutics
    • Aethlon Medical
    • Anjarium Biosciences
    • BioRegenerative Sciences
    • Capricor Therapeutics
    • Cell Factory
    • Codiak BioSciences
    • Creative Medical Technology Holdings (CMTH)
    • DreiRosen Pharma
    • Evox Therapeutics
    • ExoCoBio
    • ExoCyte Therapeutics
    • Exogenus Therapeutics
    • Exopharm
    • Exotech Bio
    • Exovita Biosciences
    • Intrexon Corp.
    • Kimera Labs
    • MDimune
    • MolecuVax
    • Panacea Pharmaceuticals, Inc.
    • Paradigm Pharmaceuticals
    • ReCyte
    • Regeneus
    • ReNeuron
    • Therapeutics Solutions International
    • Unicyte AG
    • Additional Pharma and Biotech Companies with Potential Exosome Research Projects
  • Clinical Trials as Indicator for Exosome Market Development
  • Evaluation of Current Therapeutics Sector in Exosome Market

Chapter 6: Exosome Reagents and Research Tools Market

  • Market Overview
    • Isolation Methodologies and Reagents for Exosome
    • Detection Methodologies and Reagents for Exosome Research
    • Characterization Methods and Reagents for Exosome Research
    • Engineering Methods and Reagents for Exosome Research
    • Additional Products and Reagents for Exosome Research
  • Market Participants for Reagents and Tools for Exosome Research
    • 101Bio
    • AMSBIO
    • Cell Guidance Systems
    • Ciloa
    • Evomic Science
    • Excytex
    • ExoCan
    • HansaBiomed (Lonza)
    • IZON Science
    • NanoSight (Malvern Instruments)
    • Nanoview Biosciences
    • System Biosciences (SBI)
    • Additional Market Participants for Reagents and Tools for Exosome Research
  • Evaluation of Current Tools and Reagents Sector in the Exosome Market

Chapter 7: Impact of Exosome Research on Specific Biopharmaceuticals Market

  • Exosome Research Impact on Biomarker and Diagnostics Industry
  • Exosome Research Impact on MicroRNA Market
  • Exosome Research Impact on the Liquid Biopsy Market
  • Exosome Research Impact on Stem Cell Technologies Market
  • Exosome Research Impact on Prenatal Diagnostic Market
  • Exosome Research Impact on Agriculture and Food Industry
  • Exosome Research, Microfluidics and Nanotechnology
  • Exosome Research Impact on Skincare Industry

Chapter 8: Patent Review/ New Developments

Chapter 9: Market Summary

Chapter 10: Company Profiles

About BCC Research

  • About BCC Research
  • BCC Library Access
  • BCC Custom Research

List of Tables

  • Summary Table: Global Market for the Exosome Industry, by Sector, Through 2023 ($ Millions)
  • Table 1 Nomenclature of Exosome Particles
  • Table 2 Publication Trend on the Subject of Exosome, 2003-2017 (No.of Publications)
  • Table 3 Steps in Exosome Biogenesis and Processing
  • Table 4 Proteins Essential in Exosome Biogenesis and Processing
  • Table 5 Proteins Found in Exosomes
  • Table 6 MicroRNA in Different Bodily Fluids
  • Table 7 Methods for Exosome Isolation
  • Table 8 Distribution of Exosomes Isolation Procedures in the Studies Cataloged in ExoCarta (%) ..
  • Table 9 Statistics of Data Cataloged in ExoCarta, 2012 and 2017 (Number)
  • Table 10 Statistics of Data Cataloged in Vesiclepedia, 2012 and 2017 (Number)
  • Table 11 Statistics of Data Cataloged in EVpedia, 2014
  • Table 12 Comparison of Databases for Exosome Studies
  • Table 13 Examples of Exosomal Proteins for Clinical Diagnostic Applications
  • Table 14 Examples of Exosomal MicroRNA for Clinical Diagnostic Applications
  • Table 15 Statistics for Prostate Cancer, 2017
  • Table 16 Global Market for Prostate Cancer Diagnostics and Related Cost ($ Billions)
  • Table 17 Statistics for Breast Cancer, 2017
  • Table 18 Global Market for Breast Cancer Diagnostics, Through 2019 ($ Billions)
  • Table 19 Statistics for Bladder Cancer, 2017
  • Table 20 Global Market for Bladder Cancer Diagnostics, 2017 ($ Billions)
  • Table 21 Statistics for Ovarian Cancer, 2017
  • Table 22 Global Market for Ovarian Cancer Diagnostics, 2017 ($ Millions)
  • Table 23 Statistics for Lung Cancer, 2017
  • Table 24 Global Market for Lung Cancer Diagnostics, 2017 ($ Millions)
  • Table 25 Liquid vs.Tissue Biopsy
  • Table 26 Global Market for Liquid Biopsy Including Research Tools, Services and Diagnostics, Through 2022 ($ Billions)
  • Table 27 Exosomal Protein Biomarkers from Body Fluids of Patients in Pre-clinical and Clinical Studies 49
  • Table 28 Exosomal Nucleic Acid Biomarkers in Pre-clinical and Clinical Studies
  • Table 29 U.S.Statistics Data for Alzheimer's, 2017 (Millions/$ Billions)
  • Table 30 Global Market for Alzheimer's Disease Therapeutics and Diagnostics, Through 2020 ($ Billions)
  • Table 31 Global Statistics Data for Hepatitis C Infection, 2015 (Millions)
  • Table 32 Global Market Value for Hepatitis C Diagnostics, 2017 ($ Billions)
  • Table 33 U.S.Statistics Data for Cardiovascular Diseases, 2017 (Number/$ Billions)
  • Table 34 Global Market for Cardiovascular Diagnostics, 2017 ($ Billions)
  • Table 35 Global Market for Prenatal Diagnostics, Predictive Tests and Neonatal Monitoring, Through 2019 ($ Billions)
  • Table 36 Global Market for Organ and Tissue Transplantation Products and Devices, Through 2020 ($ Billions)
  • Table 37 Comparison of Exosome-based Diagnostics Approach to Other Liquid Biopsy Platforms
  • Table 38 Main Market Participants in Exosome-based Diagnostics Sector
  • Table 39 Global Market for Exosome Diagnostics, Through 2023 ($ Millions)
  • Table 40 Examples of Physiological Effect of Exosome Delivery
  • Table 41 Top Five Vaccine Providers, 2016 ($ Billions)
  • Table 42 U.S.Statistics for Burn Injuries (Number/$ Billions)
  • Table 43 U.S.Statistics for Pressure Ulcer ($ Billions/Number)
  • Table 44 Revenues for Aethlon Medical, 2012-2016 ($ Millions)
  • Table 45 Revenue, Cost and Profits for Capricor Therapeutics, 2012-2016 ($ Millions)
  • Table 46 Main Market Participants in Exosome-based Therapeutics Sector
  • Table 47 Examples of Clinical Trials Related to Exosome Research
  • Table 48 Examples of Financing for Exosome-based Therapeutics Companies
  • Table 49 Global Market for Exosome Therapeutics, Through 2023 ($ Millions)
  • Table 50 Main Steps in Exosome Research Approach
  • Table 51 Examples of Commercial Kits and Reagents for Exosome Isolation
  • Table 52 Percentage of Use Each of Isolation Technique for Exosome Purification (%)
  • Table 53 Examples of Detection Assay
  • Table 54 Examples of Antibody Providers for Exosome Research
  • Table 55 Examples of RNA Extraction Commercial Kits
  • Table 56 Percentage of Use of Characterization Techniques for Exosome Sample (%)
  • Table 57 Examples of Purified Exosomes Commercial Products ($)
  • Table 58 Main Market Participants in Exosome Research Tools and Reagents
  • Table 59 Global Market for Exosome Research Tools and Reagents Market, Through 2023 ($ Millions) 162
  • Table 60 Examples of Protein Markers in Exosomes and Their Related Pathology
  • Table 61 Examples of MicroRNA Markers in Exosomes and Their Related Pathology
  • Table 62 Liquid vs.Tissue Biopsy
  • Table 63 Global Market for Prenatal Diagnostics, Predictive Tests and Neonatal Monitoring, Through 2019 ($ Billions)
  • Table 64 Number of Patents on Exosome Research Filed in Specific Years, 2000-2017
  • Table 65 Examples of Patents Filed on Exosome Research
  • Table 66 Search Analysis for Patents Using Specific Keywords (Number)
  • Table 67 Number of Patents and Patent Applications by Some Exosome Market Participants
  • Table 68 Global Market for Exosome Industry, by Application Sector, Through 2023 ($ Millions)
  • Table 69 Examples of Main Market Participants in Exosome Market

List of Figures

  • Summary Figure: Global Market for the Exosome Industry, by Sector, 2016-2023 ($ Millions)
  • Figure 1 Publication Trend on the Subject of Exosome, 2003-2017 (No.of Publications)
  • Figure 2 Differential Centrifugation Process
  • Figure 3 Ciliated Porous Device Designed to Isolate Exosomes by Filtration
  • Figure 4 Sieving Models for Exosome Filtration
  • Figure 5 Global Market for Exosome Diagnostics, 2016-2023 ($ Millions)
  • Figure 6 Global Market for Exosome Therapeutics, 2016-2023 ($ Millions)
  • Figure 7 Global Market for Exosome Research Tools and Reagents Market, 2016-2023 ($ Millions) ..
  • Figure 8 Number of Patents Filed in Specific Years on Exosome Research, 2000-2017
  • Figure 9 Search Analysis for Patents Using Specific Keywords (Number)
  • Figure 10 Global Market for Exosome Industry, by Application Sector, 2016-2023 ($ Millions) .
Back to Top